Silver Book

Parkinson's Disease

Parkinson’s disease is a progressive neurological disorder that impacts close to one million Americans. It leads to debilitating symptoms, comorbidities, expensive medical care, and caregiving needs. Existing therapies help manage symptoms and exciting research advances hold promise for even better management and potential cures.

With educational support from Lundbeck, Roivant Sciences, and Sunovion.

Publications

Categories

80 Matching Facts

Search matching Facts:
No results to display
    • Total Cost of Parkinson’s Disease
       
    • Total Cost Breakdown of Parkinson’s (Direct and Indirect Medical Costs)
       
    • Premature Deaths Associated with Parkinson’s Disease
       
    • Parkinson’s Patients Who Experience Various Symptoms
       
    • Parkinson’s Disease Prevalence Increases with Age
       
    • Mortality Greater for Those With Parkinson’s Disease
       
    • Men More Likely Than Women to Have Parkinson’s Disease
       
    • Government Spending for Parkinson’s Disease
       
    • Direct Medical Costs Per Person with Parkinson’s Disease Increase with Severity
       
    • Direct and Indirect Costs of Parkinson’s Disease
       
    • Average Annual Direct Medical Costs Per Person with Parkinson’s Disease
       
    • Annual Direct and Non-medical Costs Per Parkinson’s Patient
       
    • Parkinson’s Disease Medicare Beneficiaries and Long-Term Care Facilities
       
    • Health Care Visits Due to Parkinson’s disease
       
    • Risk of Fracture from Parkinson’s Disease
       
    • Parkinson’s Disease Patients Who Report Falls
       
    • Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s
       
    • Symptoms of Parkinson’s Disease Psychosis in Half of Parkinson’s Disease Patients
       
    • Early Gene Therapy Studies Show Promise for Parkinson’s Disease
       
    • Depression and Parkinson’s Disease Patients
       
    • Spinal Cord Stimulation Shows Improvements for Parkinson’s Patients
       
    • Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money
       
    • Dementia is Nearly Inevitable for Parkinson’s Disease Patients
       
    • Experience of Americans With Parkinson’s Disease Over 1 Year
       
    • Average Age of Parkinson’s Disease Diagnosis
       
    • Annual Parkinson’s Disease Cases
       
    • New Medicines in Development for Parkinson’s Disease in 2018
       
    • Parkinson’s Disease 2nd Most Common Neurodegenerative Disorder in the U.S.
       
    • Stopping the Progress of Parkinson’s Would Save >$440,000 per Person
       
    • Nearly 1 Million Americans Have Parkinson’s Disease
       
    • Slowing the Progress of Parkinson’s Disease Would Save Money
       
    • Close to half (48%) of all Parkinson’s patients report having suffered a fall.  
    • The cost of nursing homes for Parkinson’s patients totaled $5 billion in 2010.  
    • Medical expenses for Parkinson’s alone costs $8.1 billion or $12,800 per person in 2010.  
    • Therapeutic surgery for those with Parkinson’s can cost approximately $100,000 per patient.  
    • Parkinson’s disease cost our nation $25 billion each year in direct and indirect costs.  
    • Parkinson’s disease is the 14th leading cause of death in the U.S.  
    • 1 million Americans have Parkinson’s disease.  
    • Every year, 50,000 to 60,000 people are diagnosed with Parkinson’s disease.  
    • If the progression of Parkinson’s disease were slowed by 50%, there would be a 35% reduction in excess costs.  
    • 26,000 hospice days in 2010 were attributable to Parkinson’s disease.  
    • 24,000 home health days in 2010 were attributable to Parkinson’s disease.  
    • 31,000 emergency department visits in 2010 were attributable to Parkinson’s disease.  
    • 57,000 outpatient visits in 2010 were attributable to Parkinson’s disease.  
    • 1.26 million physician office visits in 2010 were attributable to Parkinson’s disease.  
    • In 2010, Parkinson’s disease was the cause of 1.9 million hospital inpatient days–73% more than is expected for a population without the disease.  
    • In addition to the estimated $14.4 billion a year in costs for Parkinson’s disease to the nation, an additional $6.3 billion in indirect costs (missed work or loss of job…  
    • The prevalence of Parkinson’s disease is expected to more than double between 2010 and 2040.  
    • Individuals with Parkinson’s disease in 2010 incurred medical expenses of $22,800 per patient (in PD-related expenses)–$12,800 higher than someone without the disease.  
    • The national economic burden of Parkinson’s disease in 20130 exceeded $14.4 billion–approximately $22,800 per patient.  
    • Health-related-quality-of-life (HRQOL) is severely affected in Parkinson’s disease. In a study of veterans, HRQOL was more impaired in Parkinson’s disease than in those with any other condition.  
    • Among nursing home residents with Parkinson’s disease, 3-year mortality was 50%.  
    • Patients with Parkinson’s disease have twice the risk of suffering a fracture, and more than 3 times the risk of a hip fracture.  
    • Patients with Parkinson’s disease account for between 2.2% and 6.8% of the nursing home population in the U.S.  
    • Major depression is present in around 20-40% of Parkinson’s disease patients.  
    • More than 3/4 of Parkinson’s disease patients developed dementia during an 8-year study.  
    • Each year, around 68% of Parkinson’s disease patients suffer from falls.  
    • The risk of death in people with Parkinson’s disease is 1.6 times that of the general population.  
    • The prevalence of Parkinson’s disease increase dramatically with age. For every 100,000 Americans, 6,317 people age 80 and over have the disease, compared with 2,785 aged 70-80 and 704 aged…  
    • The incidence of Parkinson’s disease rapidly increases over the age of 60 years–with only 4% of cases occurring under the age of 50.  
    • The average diagnosis age for Parkinson’s disease in the U.S. is 70.5 years.  
    • The lifetime risk at birth of developing Parkinson’s disease is around 2% for men and 1.3% for women.  
    • Every 9 minutes, someone in the U.S. is diagnosed with Parkinson’s disease–60,000 new cases every year.  
    • An estimated 1.5 million Americans currently have Parkinson’s disease.  
    • Parkinson’s disease is the 2nd-most common neurodegenerative disease in the U.S., second only to Alzheimer’s disease.  
    • 15% of Americans with Parkinson’s disease are diagnosed before the age of 50–incidence increases with age.  
    • Some individuals with Parkinson’s disease talk, walk, or act out dreams and nightmares in their sleep. The may inadvertently injure themselves or their bed partners in the process.  
    • Lightheadedness, drooling, and difficulty swallowing can occur because of autonomic nervous system dysfunction in Parkinson’s disease.  
    • Many studies estimate that over 90% of Parkinson’s disease patients suffer from a type of sleep disturbance.  
    • At least 1/3 of patients with Parkinson’s disease develop cognitive impairment, which can be secondary to the disease itself.  
    • Psychiatric symptoms such as depression and anxiety occur in 1/3 to 2/3 of Parkinson’s disease patients.  
    • Drug therapy for Parkinson’s disease costs more than $6 billion a year. Costs such as rehabilitation and home care can run as high as $150,000 per patient, per year.  
    • Every 9 minutes a new Parkinson’s case is diagnosed–60,000 cases every year.  
    • According to preliminary data, Parkinson’s disease was the 14th leading cause of death in the United States in 2004, causing 18,018 deaths.  
    • An estimated 33% of Parkinson’s patients suffer from falls; 13% fall more than once a week.  
    • As Parkinson’s progresses, substantial disability–including the inability to maintain balance, walk, speak, and move–makes assisted living and nursing home care necessary.  
    • By the time the symptoms of Parkinson’s disease are apparent, as much as 80% of dopamine-producing cells have been damaged.  
    • The average age of onset for Parkinson’s is 60-years-old.  
    • As many as 1 million Americans suffer from Parkinson’s disease.  
    • Parkinson’s disease is the second most common neurodegenerative disease in the United States, second only to Alzheimer’s disease.